Clearview Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-22
Closed -$4.88K 141
2023
Q2
$4.88K Hold
22
0.01% 434
2023
Q1
$5.32K Hold
22
0.01% 423
2022
Q4
$5.78K Hold
22
﹤0.01% 380
2022
Q3
$5K Sell
22
-1,664
-99% -$403K ﹤0.01% 400
2022
Q2
$410K Buy
1,686
+68
+4% +$16.7K 0.31% 62
2022
Q1
$391K Sell
1,618
-25
-2% -$5.74K 0.26% 68
2021
Q4
$370K Buy
1,643
+83
+5% +$17.5K 0.23% 87
2021
Q3
$332K Buy
1,560
+9
+0.6% +$2.07K 0.21% 89
2021
Q2
$378K Sell
1,551
-190
-11% -$46.7K 0.23% 83
2021
Q1
$433K Buy
1,741
+215
+14% +$51.3K 0.28% 71
2020
Q4
$351K Buy
+1,526
New +$352K 0.24% 78

Other funds holding AMGN

Clearview Wealth Advisors's AMGN Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of Amgen (AMGN) in Q3 2023, closing a stake of 22 shares — an estimated $4.88K sold.

Clearview Wealth Advisors first reported a position in AMGN in Q4 2020 and held it in 11 quarters. The position peaked at $433K in Q1 2021. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • Clearview Wealth Advisors reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • Clearview Wealth Advisors sold 22 Amgen shares in Q3 2023, an estimated $4.88K.
  • Clearview Wealth Advisors first reported a position in Amgen in Q4 2020 and held it in 11 quarters.
  • Clearview Wealth Advisors's Amgen position peaked at $433K in Q1 2021.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.